| 0 |
VASCULAR PSEUDOANEURYSM THROMBOSIS |
10 |
0.3704 |
| 1 |
DIABETIC MONONEUROPATHY |
1 |
0.2000 |
| 2 |
PRESBYACUSIS |
10 |
0.0325 |
| 3 |
THORACIC SPINAL STENOSIS |
1 |
0.0238 |
| 4 |
PRODUCT ORIGIN UNKNOWN |
1 |
0.0233 |
| 5 |
CARDIAC VALVE VEGETATION |
10 |
0.0206 |
| 6 |
INTERCOSTAL NEURALGIA |
3 |
0.0169 |
| 7 |
EMBOLIC CEREBRAL INFARCTION |
10 |
0.0151 |
| 8 |
HAEMOPERITONEUM |
10 |
0.0125 |
| 9 |
PERIORBITAL INFECTION |
1 |
0.0123 |
| 10 |
POST INFECTION GLOMERULONEPHRITIS |
1 |
0.0119 |
| 11 |
CAPNOCYTOPHAGA INFECTION |
1 |
0.0106 |
| 12 |
ATYPICAL MYCOBACTERIUM TEST POSITIVE |
1 |
0.0103 |
| 13 |
WOUND DRAINAGE |
8 |
0.0101 |
| 14 |
MYCOBACTERIUM CHELONAE INFECTION |
7 |
0.0095 |
| 15 |
MILLER FISHER SYNDROME |
2 |
0.0089 |
| 16 |
DERMATOPHYTOSIS OF NAIL |
1 |
0.0084 |
| 17 |
GLOMERULAR FILTRATION RATE ABNORMAL |
11 |
0.0078 |
| 18 |
TRICHOGLOSSIA |
3 |
0.0073 |
| 19 |
ATYPICAL MYCOBACTERIAL PNEUMONIA |
1 |
0.0072 |
| 20 |
GASTROINTESTINAL CANDIDIASIS |
3 |
0.0072 |
| 21 |
ENDOCARDITIS ENTEROCOCCAL |
1 |
0.0070 |
| 22 |
PRODUCT IDENTIFICATION NUMBER ISSUE |
1 |
0.0067 |
| 23 |
MEDICAL DEVICE SITE JOINT INFECTION |
1 |
0.0064 |
| 24 |
POST-TRAUMATIC HEADACHE |
1 |
0.0064 |
| 25 |
PIRIFORMIS SYNDROME |
1 |
0.0059 |
| 26 |
HEPATIC HAEMORRHAGE |
5 |
0.0058 |
| 27 |
SOCIOECONOMIC PRECARITY |
1 |
0.0058 |
| 28 |
POST LAMINECTOMY SYNDROME |
1 |
0.0058 |
| 29 |
COLOUR BLINDNESS ACQUIRED |
2 |
0.0055 |
| 30 |
CALCIUM METABOLISM DISORDER |
1 |
0.0053 |
| 31 |
TOXIC SHOCK SYNDROME STREPTOCOCCAL |
1 |
0.0052 |
| 32 |
CHOLESTATIC LIVER INJURY |
11 |
0.0049 |
| 33 |
MYCOBACTERIUM TEST POSITIVE |
1 |
0.0049 |
| 34 |
GRAM STAIN POSITIVE |
1 |
0.0049 |
| 35 |
TARSAL TUNNEL SYNDROME |
1 |
0.0045 |
| 36 |
NOCARDIOSIS |
11 |
0.0043 |
| 37 |
INJECTION SITE PHLEBITIS |
1 |
0.0043 |
| 38 |
CROSS SENSITIVITY REACTION |
4 |
0.0041 |
| 39 |
ACUTE HIV INFECTION |
1 |
0.0040 |
| 40 |
BRAIN ABSCESS |
10 |
0.0039 |
| 41 |
HYPERTENSIVE CARDIOMYOPATHY |
1 |
0.0036 |
| 42 |
SECONDARY HYPERTENSION |
1 |
0.0035 |
| 43 |
WHITE BLOOD CELL COUNT |
1 |
0.0034 |
| 44 |
BLADDER TAMPONADE |
1 |
0.0033 |
| 45 |
COOMBS DIRECT TEST POSITIVE |
1 |
0.0032 |
| 46 |
VASCULAR PAIN |
3 |
0.0031 |
| 47 |
PERIPHERAL NERVE LESION |
1 |
0.0030 |
| 48 |
CONJUNCTIVITIS BACTERIAL |
1 |
0.0029 |
| 49 |
ABSCESS BACTERIAL |
1 |
0.0028 |
| 50 |
SHOCK SYMPTOM |
1 |
0.0027 |
| 51 |
NASAL TURBINATE HYPERTROPHY |
1 |
0.0027 |
| 52 |
TOXIC NEUROPATHY |
1 |
0.0025 |
| 53 |
INFUSION |
1 |
0.0024 |
| 54 |
TOOTH DISCOLOURATION |
7 |
0.0024 |
| 55 |
BLOOD CREATININE ABNORMAL |
8 |
0.0023 |
| 56 |
HEPATIC LESION |
10 |
0.0023 |
| 57 |
TOXIC OPTIC NEUROPATHY |
1 |
0.0023 |
| 58 |
HYPERLACTACIDAEMIA |
6 |
0.0022 |
| 59 |
PROTEIN-LOSING GASTROENTEROPATHY |
1 |
0.0020 |
| 60 |
RESPIRATORY TRACT INFECTION BACTERIAL |
1 |
0.0020 |
| 61 |
PLASMAPHERESIS |
1 |
0.0019 |
| 62 |
BURSITIS INFECTIVE |
1 |
0.0018 |
| 63 |
NAIL DYSTROPHY |
1 |
0.0018 |
| 64 |
PLATELET COUNT |
1 |
0.0017 |
| 65 |
SUPERIOR VENA CAVA SYNDROME |
1 |
0.0017 |
| 66 |
CELLULITIS STAPHYLOCOCCAL |
1 |
0.0015 |
| 67 |
BICYTOPENIA |
3 |
0.0015 |
| 68 |
PRODUCT AVAILABILITY ISSUE |
33 |
0.0014 |
| 69 |
SUTURE RUPTURE |
1 |
0.0014 |
| 70 |
PRODUCT DESIGN ISSUE |
1 |
0.0014 |
| 71 |
MYCOBACTERIUM ABSCESSUS INFECTION |
1 |
0.0014 |
| 72 |
BRADYPHRENIA |
9 |
0.0014 |
| 73 |
IMPLANT SITE EXTRAVASATION |
1 |
0.0013 |
| 74 |
PRODUCT SUPPLY ISSUE |
9 |
0.0013 |
| 75 |
INCISION SITE HAEMORRHAGE |
1 |
0.0012 |
| 76 |
SHOCK HAEMORRHAGIC |
10 |
0.0012 |
| 77 |
PULMONARY NOCARDIOSIS |
1 |
0.0012 |
| 78 |
INCORRECT PRODUCT FORMULATION ADMINISTERED |
1 |
0.0011 |
| 79 |
CYSTIC FIBROSIS RESPIRATORY INFECTION SUPPRESSION |
1 |
0.0011 |
| 80 |
OROPHARYNGEAL CANDIDIASIS |
1 |
0.0011 |
| 81 |
MUSCLE NECROSIS |
1 |
0.0011 |
| 82 |
SEROTONIN SYNDROME |
21 |
0.0011 |
| 83 |
CERUMEN IMPACTION |
1 |
0.0011 |
| 84 |
HAEMOPHILUS INFECTION |
1 |
0.0010 |
| 85 |
HEPATIC CYTOLYSIS |
13 |
0.0010 |
| 86 |
RENAL HAEMORRHAGE |
2 |
0.0010 |
| 87 |
ANAEMIA MACROCYTIC |
2 |
0.0009 |
| 88 |
CARDIAC OPERATION |
8 |
0.0009 |
| 89 |
PEPTIC ULCER |
3 |
0.0009 |
| 90 |
PSEUDOMEMBRANOUS COLITIS |
2 |
0.0009 |
| 91 |
INCORRECT PRODUCT ADMINISTRATION DURATION |
19 |
0.0009 |
| 92 |
ARTERIAL HAEMORRHAGE |
1 |
0.0009 |
| 93 |
ACUTE LUNG INJURY |
1 |
0.0008 |
| 94 |
PERIPHERAL SENSORIMOTOR NEUROPATHY |
1 |
0.0008 |
| 95 |
GLUCOSE URINE PRESENT |
1 |
0.0008 |
| 96 |
CACHEXIA |
4 |
0.0008 |
| 97 |
APLASTIC ANAEMIA |
4 |
0.0008 |
| 98 |
ORGAN FAILURE |
3 |
0.0007 |
| 99 |
CYSTIC FIBROSIS |
4 |
0.0007 |
| 100 |
CATAPLEXY |
1 |
0.0007 |
| 101 |
GENITAL RASH |
1 |
0.0007 |
| 102 |
TOXIC SKIN ERUPTION |
7 |
0.0007 |
| 103 |
VOMITING PROJECTILE |
2 |
0.0007 |
| 104 |
METABOLIC ENCEPHALOPATHY |
2 |
0.0007 |
| 105 |
PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE |
4 |
0.0007 |
| 106 |
DIABETIC FOOT |
2 |
0.0007 |
| 107 |
GASTROINTESTINAL STOMA COMPLICATION |
1 |
0.0006 |
| 108 |
EOSINOPHILIC PNEUMONIA |
2 |
0.0006 |
| 109 |
HYPERTENSIVE CRISIS |
7 |
0.0006 |
| 110 |
PANCYTOPENIA |
34 |
0.0006 |
| 111 |
MEDICAL PROCEDURE |
1 |
0.0006 |
| 112 |
NEPHRITIS |
2 |
0.0006 |
| 113 |
WOUND INFECTION STAPHYLOCOCCAL |
1 |
0.0006 |
| 114 |
VASCULAR PSEUDOANEURYSM |
1 |
0.0006 |
| 115 |
PURPURA |
5 |
0.0006 |
| 116 |
LUNG TRANSPLANT |
2 |
0.0006 |
| 117 |
THROMBOCYTOPENIA |
62 |
0.0006 |
| 118 |
SOFT TISSUE INFECTION |
1 |
0.0005 |
| 119 |
ESSENTIAL HYPERTENSION |
1 |
0.0005 |
| 120 |
BODY TEMPERATURE ABNORMAL |
1 |
0.0005 |
| 121 |
MECHANICAL VENTILATION |
1 |
0.0005 |
| 122 |
POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME |
5 |
0.0005 |
| 123 |
PNEUMONIA CYTOMEGALOVIRAL |
1 |
0.0005 |
| 124 |
PROCEDURAL HAEMORRHAGE |
2 |
0.0005 |
| 125 |
HYPOGEUSIA |
1 |
0.0005 |
| 126 |
PNEUMONIA STAPHYLOCOCCAL |
1 |
0.0005 |
| 127 |
PRODUCT PRESCRIBING ISSUE |
11 |
0.0005 |
| 128 |
MYOCLONUS |
6 |
0.0005 |
| 129 |
NIPPLE PAIN |
1 |
0.0005 |
| 130 |
PANCREATITIS ACUTE |
11 |
0.0005 |
| 131 |
INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION |
5 |
0.0005 |
| 132 |
STAPHYLOCOCCUS TEST POSITIVE |
1 |
0.0005 |
| 133 |
OPTIC NEUROPATHY |
1 |
0.0005 |
| 134 |
STAPHYLOCOCCAL BACTERAEMIA |
2 |
0.0005 |
| 135 |
MULTIPLE ORGAN DYSFUNCTION SYNDROME |
13 |
0.0005 |
| 136 |
DENTAL CARIES |
5 |
0.0005 |
| 137 |
PRODUCT PACKAGE ASSOCIATED INJURY |
1 |
0.0004 |
| 138 |
TONGUE BLISTERING |
1 |
0.0004 |
| 139 |
SYNOVIAL CYST |
2 |
0.0004 |
| 140 |
ARTHRITIS INFECTIVE |
2 |
0.0004 |
| 141 |
HYPOMAGNESAEMIA |
6 |
0.0004 |
| 142 |
BILIRUBIN CONJUGATED INCREASED |
1 |
0.0004 |
| 143 |
VARICELLA |
1 |
0.0004 |
| 144 |
OXYGEN CONSUMPTION INCREASED |
1 |
0.0004 |
| 145 |
ENTEROCOCCAL INFECTION |
2 |
0.0004 |
| 146 |
GASTROINTESTINAL TUBE INSERTION |
1 |
0.0004 |
| 147 |
EOSINOPHILIA |
7 |
0.0004 |
| 148 |
PHLEBITIS |
2 |
0.0004 |
| 149 |
PRODUCT PACKAGING DIFFICULT TO OPEN |
1 |
0.0004 |
| 150 |
WHITE BLOOD CELL DISORDER |
1 |
0.0004 |
| 151 |
EAR CONGESTION |
1 |
0.0004 |
| 152 |
LARGE INTESTINAL ULCER |
1 |
0.0004 |
| 153 |
INFECTIVE PULMONARY EXACERBATION OF CYSTIC FIBROSIS |
2 |
0.0004 |
| 154 |
LIP BLISTER |
1 |
0.0004 |
| 155 |
ORAL FUNGAL INFECTION |
1 |
0.0004 |
| 156 |
DRUG LEVEL BELOW THERAPEUTIC |
2 |
0.0004 |
| 157 |
INTRACRANIAL PRESSURE INCREASED |
2 |
0.0004 |
| 158 |
PRODUCT USE IN UNAPPROVED INDICATION |
88 |
0.0004 |
| 159 |
HEPATOCELLULAR INJURY |
5 |
0.0004 |
| 160 |
ADENOVIRUS INFECTION |
1 |
0.0003 |
| 161 |
LUMBAR SPINAL STENOSIS |
1 |
0.0003 |
| 162 |
NECK INJURY |
1 |
0.0003 |
| 163 |
CATARACT OPERATION |
2 |
0.0003 |
| 164 |
MIXED LIVER INJURY |
1 |
0.0003 |
| 165 |
CENTRAL VENOUS CATHETERISATION |
1 |
0.0003 |
| 166 |
OPTIC NEURITIS |
3 |
0.0003 |
| 167 |
MASTICATION DISORDER |
1 |
0.0003 |
| 168 |
TINNITUS |
15 |
0.0003 |
| 169 |
ISCHAEMIC CARDIOMYOPATHY |
1 |
0.0003 |
| 170 |
MULTIPLE-DRUG RESISTANCE |
1 |
0.0003 |
| 171 |
CHOLESTASIS |
6 |
0.0003 |
| 172 |
ROTATOR CUFF SYNDROME |
4 |
0.0003 |
| 173 |
BACTERIAL SEPSIS |
1 |
0.0003 |
| 174 |
INABILITY TO AFFORD MEDICATION |
3 |
0.0003 |
| 175 |
CARDIAC FAILURE ACUTE |
2 |
0.0003 |
| 176 |
POTENTIATING DRUG INTERACTION |
1 |
0.0003 |
| 177 |
WOUND DEHISCENCE |
1 |
0.0003 |
| 178 |
EAR DISCOMFORT |
3 |
0.0003 |
| 179 |
WOUND COMPLICATION |
1 |
0.0003 |
| 180 |
INTERNATIONAL NORMALISED RATIO ABNORMAL |
1 |
0.0003 |
| 181 |
ERYTHEMA NODOSUM |
1 |
0.0003 |
| 182 |
MACULOPATHY |
1 |
0.0003 |
| 183 |
OSTEOMYELITIS |
5 |
0.0003 |
| 184 |
ANAEMIA |
51 |
0.0003 |
| 185 |
THROAT CLEARING |
1 |
0.0003 |
| 186 |
REHABILITATION THERAPY |
1 |
0.0003 |
| 187 |
WOUND SECRETION |
1 |
0.0003 |
| 188 |
SKIN PAPILLOMA |
1 |
0.0002 |
| 189 |
BLEPHARITIS |
1 |
0.0002 |
| 190 |
CYSTITIS HAEMORRHAGIC |
1 |
0.0002 |
| 191 |
LACTIC ACIDOSIS |
8 |
0.0002 |
| 192 |
PERIPHERAL ARTERIAL OCCLUSIVE DISEASE |
1 |
0.0002 |
| 193 |
LEG AMPUTATION |
1 |
0.0002 |
| 194 |
AORTIC DISSECTION |
1 |
0.0002 |
| 195 |
DRUG EFFECTIVE FOR UNAPPROVED INDICATION |
7 |
0.0002 |
| 196 |
NO ADVERSE EVENT |
43 |
0.0002 |
| 197 |
MUSCLE FATIGUE |
1 |
0.0002 |
| 198 |
AORTIC VALVE INCOMPETENCE |
1 |
0.0002 |
| 199 |
HEPATITIS |
6 |
0.0002 |
| 200 |
INTERVERTEBRAL DISC DISORDER |
1 |
0.0002 |
| 201 |
PURULENT DISCHARGE |
1 |
0.0002 |
| 202 |
PULMONARY FUNCTION TEST DECREASED |
1 |
0.0002 |
| 203 |
PARONYCHIA |
1 |
0.0002 |
| 204 |
IMMUNOSUPPRESSION |
2 |
0.0002 |
| 205 |
LIGAMENT RUPTURE |
1 |
0.0002 |
| 206 |
BLOOD CREATINE INCREASED |
1 |
0.0002 |
| 207 |
SUSPECTED OFF LABEL USE |
1 |
0.0002 |
| 208 |
PATHOGEN RESISTANCE |
2 |
0.0002 |
| 209 |
THERAPEUTIC PRODUCT EFFECT DELAYED |
1 |
0.0002 |
| 210 |
HAEMOGLOBIN INCREASED |
1 |
0.0002 |
| 211 |
DISEASE COMPLICATION |
1 |
0.0002 |
| 212 |
AGRANULOCYTOSIS |
4 |
0.0002 |
| 213 |
ROSACEA |
1 |
0.0002 |
| 214 |
STAPHYLOCOCCAL INFECTION |
7 |
0.0002 |
| 215 |
HUMERUS FRACTURE |
1 |
0.0002 |
| 216 |
PANCREATIC DISORDER |
1 |
0.0002 |
| 217 |
STAPHYLOCOCCAL SEPSIS |
1 |
0.0002 |
| 218 |
VENOOCCLUSIVE LIVER DISEASE |
1 |
0.0002 |
| 219 |
IMMUNODEFICIENCY |
3 |
0.0002 |
| 220 |
IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME |
1 |
0.0002 |
| 221 |
HEPATIC ENZYME ABNORMAL |
1 |
0.0002 |
| 222 |
NEUROPATHY PERIPHERAL |
19 |
0.0002 |
| 223 |
PNEUMOCYSTIS JIROVECII PNEUMONIA |
2 |
0.0002 |
| 224 |
TOOTH ABSCESS |
2 |
0.0002 |
| 225 |
FAILURE TO THRIVE |
1 |
0.0002 |
| 226 |
BLOOD LACTIC ACID INCREASED |
1 |
0.0002 |
| 227 |
GAMMA-GLUTAMYLTRANSFERASE INCREASED |
4 |
0.0002 |
| 228 |
TRANSAMINASES INCREASED |
4 |
0.0002 |
| 229 |
NECROSIS |
1 |
0.0002 |
| 230 |
ACUTE PULMONARY OEDEMA |
1 |
0.0002 |
| 231 |
ADVERSE EVENT |
16 |
0.0002 |
| 232 |
PERIPHERAL SENSORY NEUROPATHY |
1 |
0.0002 |
| 233 |
HYPERTRIGLYCERIDAEMIA |
1 |
0.0002 |
| 234 |
ACUTE RESPIRATORY DISTRESS SYNDROME |
3 |
0.0002 |
| 235 |
BACTERAEMIA |
2 |
0.0002 |
| 236 |
BLOOD CREATININE INCREASED |
11 |
0.0002 |
| 237 |
RHABDOMYOLYSIS |
7 |
0.0002 |
| 238 |
HEPATITIS CHOLESTATIC |
1 |
0.0002 |
| 239 |
BURSITIS |
2 |
0.0002 |
| 240 |
MENISCUS INJURY |
1 |
0.0002 |
| 241 |
INFUSION SITE EXTRAVASATION |
1 |
0.0002 |
| 242 |
SECRETION DISCHARGE |
2 |
0.0002 |
| 243 |
CELLULITIS |
8 |
0.0002 |
| 244 |
ENTERITIS |
1 |
0.0002 |
| 245 |
PLATELET COUNT INCREASED |
2 |
0.0002 |
| 246 |
PRODUCT PREPARATION ISSUE |
1 |
0.0002 |
| 247 |
HYPOGAMMAGLOBULINAEMIA |
1 |
0.0002 |
| 248 |
DYSGRAPHIA |
1 |
0.0002 |
| 249 |
APPETITE DISORDER |
1 |
0.0002 |
| 250 |
VISUAL ACUITY REDUCED |
5 |
0.0002 |
| 251 |
LIMB INJURY |
4 |
0.0001 |
| 252 |
JOINT EFFUSION |
1 |
0.0001 |
| 253 |
PROCEDURAL PAIN |
4 |
0.0001 |
| 254 |
PAPULE |
1 |
0.0001 |
| 255 |
PULMONARY TOXICITY |
1 |
0.0001 |
| 256 |
LYMPHOPENIA |
2 |
0.0001 |
| 257 |
HAND FRACTURE |
1 |
0.0001 |
| 258 |
DRUG ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE |
1 |
0.0001 |
| 259 |
PANIC REACTION |
1 |
0.0001 |
| 260 |
MAJOR DEPRESSION |
1 |
0.0001 |
| 261 |
BLOOD PRESSURE DIASTOLIC DECREASED |
1 |
0.0001 |
| 262 |
FEELING DRUNK |
1 |
0.0001 |
| 263 |
PAROSMIA |
1 |
0.0001 |
| 264 |
HEPATOCELLULAR CARCINOMA |
1 |
0.0001 |
| 265 |
TROPONIN INCREASED |
1 |
0.0001 |
| 266 |
INSURANCE ISSUE |
2 |
0.0001 |
| 267 |
ANKLE FRACTURE |
2 |
0.0001 |
| 268 |
CONCUSSION |
1 |
0.0001 |
| 269 |
HYPOALBUMINAEMIA |
1 |
0.0001 |
| 270 |
OFF LABEL USE |
110 |
0.0001 |
| 271 |
BLOOD DISORDER |
1 |
0.0001 |
| 272 |
FRUSTRATION TOLERANCE DECREASED |
1 |
0.0001 |
| 273 |
PRESYNCOPE |
3 |
0.0001 |
| 274 |
POST PROCEDURAL INFECTION |
1 |
0.0001 |
| 275 |
DECUBITUS ULCER |
1 |
0.0001 |
| 276 |
PLATELET COUNT DECREASED |
13 |
0.0001 |
| 277 |
UPPER-AIRWAY COUGH SYNDROME |
1 |
0.0001 |
| 278 |
SPINAL COMPRESSION FRACTURE |
1 |
0.0001 |
| 279 |
BLOOD ALKALINE PHOSPHATASE INCREASED |
3 |
0.0001 |
| 280 |
BLOOD UREA INCREASED |
2 |
0.0001 |
| 281 |
HAEMODIALYSIS |
1 |
0.0001 |
| 282 |
CANDIDA INFECTION |
2 |
0.0001 |
| 283 |
ACUTE KIDNEY INJURY |
18 |
0.0001 |
| 284 |
MUSCLE STRAIN |
1 |
0.0001 |
| 285 |
BLOOD CALCIUM INCREASED |
1 |
0.0001 |
| 286 |
HEAD DISCOMFORT |
2 |
0.0001 |
| 287 |
MYELOSUPPRESSION |
4 |
0.0001 |
| 288 |
LEUKOCYTOSIS |
2 |
0.0001 |
| 289 |
NEUTROPENIA |
15 |
0.0001 |
| 290 |
SKIN LESION |
3 |
0.0001 |
| 291 |
PRODUCT DOSE OMISSION ISSUE |
32 |
0.0001 |
| 292 |
PRODUCT DISTRIBUTION ISSUE |
1 |
0.0001 |
| 293 |
BACTERIAL INFECTION |
2 |
0.0001 |
| 294 |
INCORRECT DRUG ADMINISTRATION DURATION |
3 |
0.0001 |
| 295 |
PULMONARY EMBOLISM |
10 |
0.0001 |
| 296 |
AUTOIMMUNE DISORDER |
1 |
0.0001 |
| 297 |
VITAMIN D DEFICIENCY |
1 |
0.0001 |
| 298 |
INFLAMMATORY BOWEL DISEASE |
1 |
0.0001 |
| 299 |
PHARYNGEAL SWELLING |
1 |
0.0001 |
| 300 |
HAEMATOCRIT DECREASED |
2 |
0.0001 |
| 301 |
HEPATIC FAILURE |
3 |
0.0001 |
| 302 |
VERTIGO |
6 |
0.0001 |
| 303 |
EPILEPSY |
3 |
0.0001 |
| 304 |
MOTOR DYSFUNCTION |
1 |
0.0001 |
| 305 |
TEMPERATURE INTOLERANCE |
1 |
0.0001 |
| 306 |
HYPERBILIRUBINAEMIA |
1 |
0.0001 |
| 307 |
DRUG INTERACTION |
15 |
0.0001 |
| 308 |
CLOSTRIDIUM DIFFICILE COLITIS |
1 |
0.0001 |
| 309 |
BRADYCARDIA |
5 |
0.0001 |
| 310 |
POOR QUALITY SLEEP |
2 |
0.0001 |
| 311 |
IMPAIRED HEALING |
3 |
0.0001 |
| 312 |
WOUND INFECTION |
1 |
0.0001 |
| 313 |
ASPIRATION |
1 |
0.0001 |
| 314 |
HOSPITALISATION |
14 |
0.0001 |
| 315 |
MELAENA |
2 |
0.0001 |
| 316 |
SKIN INFECTION |
1 |
0.0001 |
| 317 |
NEPHROPATHY TOXIC |
1 |
0.0001 |
| 318 |
BLOOD CALCIUM DECREASED |
1 |
0.0001 |
| 319 |
CHROMATURIA |
2 |
0.0001 |
| 320 |
ELECTROLYTE IMBALANCE |
1 |
0.0001 |
| 321 |
DYSPHONIA |
5 |
0.0001 |
| 322 |
MUSCLE RIGIDITY |
1 |
0.0001 |
| 323 |
WRIST FRACTURE |
1 |
0.0001 |
| 324 |
DRUG INTOLERANCE |
8 |
0.0001 |
| 325 |
LOCALISED INFECTION |
2 |
0.0001 |
| 326 |
PARAESTHESIA |
13 |
0.0001 |
| 327 |
CYTOPENIA |
1 |
0.0001 |
| 328 |
ENCEPHALOPATHY |
2 |
0.0001 |
| 329 |
GLOMERULAR FILTRATION RATE DECREASED |
1 |
0.0001 |
| 330 |
SMALL INTESTINAL OBSTRUCTION |
1 |
0.0001 |
| 331 |
TENDON RUPTURE |
1 |
0.0001 |
| 332 |
DYSGEUSIA |
6 |
0.0001 |
| 333 |
CYST |
1 |
0.0001 |
| 334 |
HEPATIC FUNCTION ABNORMAL |
3 |
0.0001 |
| 335 |
HAIR COLOUR CHANGES |
1 |
0.0001 |
| 336 |
PRODUCT USE ISSUE |
15 |
0.0001 |
| 337 |
DYSPNOEA EXERTIONAL |
3 |
0.0001 |
| 338 |
DRUG RESISTANCE |
2 |
0.0001 |
| 339 |
HAND DEFORMITY |
1 |
0.0001 |
| 340 |
QUALITY OF LIFE DECREASED |
1 |
0.0001 |
| 341 |
SINUS CONGESTION |
1 |
0.0001 |
| 342 |
HAEMATOCHEZIA |
4 |
0.0001 |
| 343 |
GASTROINTESTINAL HAEMORRHAGE |
6 |
0.0001 |
| 344 |
SEPSIS |
8 |
0.0001 |
| 345 |
HAEMOPTYSIS |
2 |
0.0001 |
| 346 |
CARPAL TUNNEL SYNDROME |
1 |
0.0001 |
| 347 |
BLINDNESS UNILATERAL |
1 |
0.0001 |
| 348 |
SINUS TACHYCARDIA |
1 |
0.0001 |
| 349 |
BRONCHOSPASM |
1 |
0.0001 |
| 350 |
SEPTIC SHOCK |
3 |
0.0001 |
| 351 |
HAEMOGLOBIN DECREASED |
7 |
0.0001 |
| 352 |
COLON CANCER |
1 |
0.0001 |
| 353 |
THROAT IRRITATION |
3 |
0.0001 |
| 354 |
ILL-DEFINED DISORDER |
4 |
0.0001 |
| 355 |
NEPHROLITHIASIS |
3 |
0.0001 |
| 356 |
FEELING HOT |
4 |
0.0001 |
| 357 |
PHARYNGEAL OEDEMA |
1 |
0.0001 |
| 358 |
DELUSION |
1 |
0.0001 |
| 359 |
ACUTE MYELOID LEUKAEMIA |
1 |
0.0001 |
| 360 |
BLOOD LACTATE DEHYDROGENASE INCREASED |
1 |
0.0001 |
| 361 |
PNEUMOTHORAX |
1 |
0.0001 |
| 362 |
RESPIRATORY TRACT CONGESTION |
1 |
0.0001 |
| 363 |
SCIATICA |
1 |
0.0001 |
| 364 |
ABSCESS |
1 |
0.0001 |
| 365 |
GASTROOESOPHAGEAL REFLUX DISEASE |
5 |
0.0001 |
| 366 |
HYPERHIDROSIS |
8 |
0.0001 |
| 367 |
PRODUCT DOSE OMISSION |
4 |
0.0001 |
| 368 |
GENERALISED TONIC-CLONIC SEIZURE |
1 |
0.0001 |
| 369 |
RENAL IMPAIRMENT |
5 |
0.0001 |
| 370 |
FACE OEDEMA |
1 |
0.0001 |
| 371 |
CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR |
2 |
0.0001 |
| 372 |
HAEMATURIA |
2 |
0.0001 |
| 373 |
VISION BLURRED |
8 |
0.0001 |
| 374 |
PARANOIA |
1 |
0.0001 |
| 375 |
GAIT DISTURBANCE |
11 |
0.0001 |
| 376 |
ORTHOSTATIC HYPOTENSION |
1 |
0.0001 |
| 377 |
RASH |
25 |
0.0001 |
| 378 |
NAUSEA |
45 |
0.0001 |
| 379 |
ASPARTATE AMINOTRANSFERASE INCREASED |
3 |
0.0001 |
| 380 |
DRUG ERUPTION |
1 |
0.0001 |
| 381 |
PELVIC PAIN |
1 |
0.0001 |
| 382 |
HYPERGLYCAEMIA |
2 |
0.0001 |
| 383 |
PRODUCT ADMINISTERED AT INAPPROPRIATE SITE |
1 |
0.0001 |
| 384 |
BLOOD GLUCOSE ABNORMAL |
1 |
0.0001 |
| 385 |
CONJUNCTIVITIS |
1 |
0.0001 |
| 386 |
MIDDLE INSOMNIA |
1 |
0.0001 |
| 387 |
TUBULOINTERSTITIAL NEPHRITIS |
1 |
0.0001 |
| 388 |
BLOOD URINE PRESENT |
1 |
0.0001 |
| 389 |
FEELING JITTERY |
1 |
0.0001 |
| 390 |
DYSTONIA |
1 |
0.0001 |
| 391 |
CATARACT |
3 |
0.0001 |
| 392 |
TASTE DISORDER |
1 |
0.0000 |
| 393 |
BONE MARROW FAILURE |
1 |
0.0000 |
| 394 |
NEUTROPHIL COUNT DECREASED |
2 |
0.0000 |
| 395 |
ILLNESS |
5 |
0.0000 |
| 396 |
FALL |
16 |
0.0000 |
| 397 |
KNEE ARTHROPLASTY |
1 |
0.0000 |
| 398 |
HALLUCINATION, VISUAL |
1 |
0.0000 |
| 399 |
HYPOACUSIS |
2 |
0.0000 |
| 400 |
ALTERED STATE OF CONSCIOUSNESS |
1 |
0.0000 |
| 401 |
CLOSTRIDIUM DIFFICILE INFECTION |
1 |
0.0000 |
| 402 |
INTERVERTEBRAL DISC PROTRUSION |
1 |
0.0000 |
| 403 |
STEVENS-JOHNSON SYNDROME |
1 |
0.0000 |
| 404 |
VOMITING |
21 |
0.0000 |
| 405 |
ORAL PAIN |
1 |
0.0000 |
| 406 |
HEPATIC ENZYME INCREASED |
3 |
0.0000 |
| 407 |
THERAPY INTERRUPTED |
3 |
0.0000 |
| 408 |
DIARRHOEA |
27 |
0.0000 |
| 409 |
URTICARIA |
7 |
0.0000 |
| 410 |
ABDOMINAL DISCOMFORT |
7 |
0.0000 |
| 411 |
DIABETIC KETOACIDOSIS |
1 |
0.0000 |
| 412 |
HEPATIC CANCER |
1 |
0.0000 |
| 413 |
INTERSTITIAL LUNG DISEASE |
2 |
0.0000 |
| 414 |
HYPOGLYCAEMIA |
2 |
0.0000 |
| 415 |
LIVER INJURY |
1 |
0.0000 |
| 416 |
AGEUSIA |
1 |
0.0000 |
| 417 |
CONDITION AGGRAVATED |
12 |
0.0000 |
| 418 |
ERYTHEMA |
8 |
0.0000 |
| 419 |
DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS |
1 |
0.0000 |
| 420 |
RASH GENERALISED |
1 |
0.0000 |
| 421 |
DEAFNESS |
1 |
0.0000 |
| 422 |
MUCOSAL INFLAMMATION |
1 |
0.0000 |
| 423 |
ANHEDONIA |
1 |
0.0000 |
| 424 |
JAUNDICE |
1 |
0.0000 |
| 425 |
RASH PRURITIC |
2 |
0.0000 |
| 426 |
PNEUMONITIS |
1 |
0.0000 |
| 427 |
DRUG INEFFECTIVE FOR UNAPPROVED INDICATION |
2 |
0.0000 |
| 428 |
ANAPHYLACTIC REACTION |
2 |
0.0000 |
| 429 |
DIVERTICULITIS |
1 |
0.0000 |
| 430 |
MENTAL STATUS CHANGES |
1 |
0.0000 |
| 431 |
NECK PAIN |
2 |
0.0000 |
| 432 |
DEMENTIA |
1 |
0.0000 |
| 433 |
HYPONATRAEMIA |
2 |
0.0000 |
| 434 |
PRODUCT DOSE OMISSION IN ERROR |
1 |
0.0000 |
| 435 |
INFECTION |
5 |
0.0000 |
| 436 |
DECREASED APPETITE |
8 |
0.0000 |
| 437 |
INTENTIONAL PRODUCT USE ISSUE |
3 |
0.0000 |
| 438 |
SURGERY |
2 |
0.0000 |
| 439 |
ABDOMINAL PAIN UPPER |
7 |
0.0000 |
| 440 |
PRURITUS |
13 |
0.0000 |
| 441 |
RESPIRATORY DISORDER |
1 |
0.0000 |
| 442 |
INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION |
6 |
0.0000 |
| 443 |
DRUG ADMINISTRATION ERROR |
1 |
0.0000 |
| 444 |
ALANINE AMINOTRANSFERASE INCREASED |
2 |
0.0000 |
| 445 |
PERIPHERAL SWELLING |
5 |
0.0000 |
| 446 |
FEMUR FRACTURE |
1 |
0.0000 |
| 447 |
WEIGHT DECREASED |
9 |
0.0000 |
| 448 |
SWOLLEN TONGUE |
1 |
0.0000 |
| 449 |
DRUG-INDUCED LIVER INJURY |
1 |
0.0000 |
| 450 |
MIGRAINE |
3 |
0.0000 |
| 451 |
NIGHT SWEATS |
1 |
0.0000 |
| 452 |
SWELLING FACE |
2 |
0.0000 |
| 453 |
EYE DISORDER |
1 |
0.0000 |
| 454 |
TREMOR |
5 |
0.0000 |
| 455 |
EXPIRED PRODUCT ADMINISTERED |
1 |
0.0000 |
| 456 |
VIRAL INFECTION |
1 |
0.0000 |
| 457 |
DYSPNOEA |
17 |
0.0000 |
| 458 |
FUNGAL INFECTION |
1 |
0.0000 |
| 459 |
GAIT INABILITY |
1 |
0.0000 |
| 460 |
TYPE 2 DIABETES MELLITUS |
1 |
0.0000 |
| 461 |
TRANSIENT ISCHAEMIC ATTACK |
1 |
0.0000 |
| 462 |
RASH MACULAR |
1 |
0.0000 |
| 463 |
THERAPEUTIC PRODUCT EFFECT INCOMPLETE |
2 |
0.0000 |
| 464 |
CEREBRAL HAEMORRHAGE |
1 |
0.0000 |
| 465 |
DRUG EFFECT INCOMPLETE |
1 |
0.0000 |
| 466 |
DRUG INEFFECTIVE |
36 |
0.0000 |
| 467 |
ASTHMA |
3 |
0.0000 |
| 468 |
INTESTINAL OBSTRUCTION |
1 |
0.0000 |
| 469 |
UNEVALUABLE EVENT |
2 |
0.0000 |
| 470 |
WHITE BLOOD CELL COUNT INCREASED |
1 |
0.0000 |
| 471 |
COUGH |
7 |
0.0000 |
| 472 |
PNEUMONIA |
8 |
0.0000 |
| 473 |
BLINDNESS |
1 |
0.0000 |
| 474 |
DIZZINESS |
12 |
0.0000 |
| 475 |
HEADACHE |
15 |
0.0000 |
| 476 |
SKIN EXFOLIATION |
2 |
0.0000 |
| 477 |
OSTEOARTHRITIS |
1 |
0.0000 |
| 478 |
URINARY TRACT INFECTION |
4 |
0.0000 |
| 479 |
BALANCE DISORDER |
2 |
0.0000 |
| 480 |
DEVICE LEAKAGE |
1 |
0.0000 |
| 481 |
ANGIOEDEMA |
1 |
0.0000 |
| 482 |
TACHYCARDIA |
2 |
0.0000 |
| 483 |
DEHYDRATION |
3 |
0.0000 |
| 484 |
PULMONARY OEDEMA |
1 |
0.0000 |
| 485 |
GASTROINTESTINAL DISORDER |
2 |
0.0000 |
| 486 |
PRODUCT QUALITY ISSUE |
3 |
0.0000 |
| 487 |
DEATH |
19 |
0.0000 |
| 488 |
INCORRECT DOSE ADMINISTERED |
5 |
0.0000 |
| 489 |
FATIGUE |
17 |
0.0000 |
| 490 |
SKIN DISCOLOURATION |
1 |
0.0000 |
| 491 |
HYPOKALAEMIA |
1 |
0.0000 |
| 492 |
OROPHARYNGEAL PAIN |
2 |
0.0000 |
| 493 |
CHEST PAIN |
4 |
0.0000 |
| 494 |
ABDOMINAL PAIN |
5 |
0.0000 |
| 495 |
SWELLING |
2 |
0.0000 |
| 496 |
ASTHENIA |
8 |
0.0000 |
| 497 |
ANXIETY |
6 |
0.0000 |
| 498 |
DISEASE RECURRENCE |
1 |
0.0000 |
| 499 |
COMA |
1 |
0.0000 |
| 500 |
PRODUCTIVE COUGH |
1 |
0.0000 |
| 501 |
RASH ERYTHEMATOUS |
1 |
0.0000 |
| 502 |
MULTIPLE SCLEROSIS |
1 |
0.0000 |
| 503 |
LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES |
1 |
0.0000 |
| 504 |
ATRIAL FIBRILLATION |
2 |
0.0000 |
| 505 |
DYSPEPSIA |
2 |
0.0000 |
| 506 |
PYREXIA |
7 |
0.0000 |
| 507 |
HYPOAESTHESIA |
3 |
0.0000 |
| 508 |
LEUKOPENIA |
1 |
0.0000 |
| 509 |
SYNCOPE |
2 |
0.0000 |
| 510 |
THERAPY CESSATION |
1 |
0.0000 |
| 511 |
HAEMORRHAGE |
2 |
0.0000 |
| 512 |
MUSCULOSKELETAL PAIN |
1 |
0.0000 |
| 513 |
WHITE BLOOD CELL COUNT DECREASED |
2 |
0.0000 |
| 514 |
OEDEMA |
1 |
0.0000 |
| 515 |
CONSTIPATION |
4 |
0.0000 |
| 516 |
TREATMENT NONCOMPLIANCE |
1 |
0.0000 |
| 517 |
OXYGEN SATURATION DECREASED |
1 |
0.0000 |
| 518 |
MYALGIA |
3 |
0.0000 |
| 519 |
BACK PAIN |
4 |
0.0000 |
| 520 |
MYOCARDIAL INFARCTION |
3 |
0.0000 |
| 521 |
PALPITATIONS |
2 |
0.0000 |
| 522 |
BONE PAIN |
1 |
0.0000 |
| 523 |
CHILLS |
2 |
0.0000 |
| 524 |
NASAL CONGESTION |
1 |
0.0000 |
| 525 |
JOINT SWELLING |
2 |
0.0000 |
| 526 |
THERAPEUTIC RESPONSE DECREASED |
1 |
0.0000 |
| 527 |
STOMATITIS |
1 |
0.0000 |
| 528 |
DISCOMFORT |
1 |
0.0000 |
| 529 |
VISUAL IMPAIRMENT |
2 |
0.0000 |
| 530 |
BLOOD GLUCOSE INCREASED |
3 |
0.0000 |
| 531 |
LOSS OF CONSCIOUSNESS |
2 |
0.0000 |
| 532 |
RHINORRHOEA |
1 |
0.0000 |
| 533 |
AMNESIA |
1 |
0.0000 |
| 534 |
INFUSION RELATED REACTION |
1 |
0.0000 |
| 535 |
FEBRILE NEUTROPENIA |
1 |
0.0000 |
| 536 |
RENAL FAILURE |
2 |
0.0000 |
| 537 |
BLOOD PRESSURE DECREASED |
1 |
0.0000 |
| 538 |
NEOPLASM MALIGNANT |
1 |
0.0000 |
| 539 |
INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION |
1 |
0.0000 |
| 540 |
RESPIRATORY FAILURE |
1 |
0.0000 |
| 541 |
AGITATION |
1 |
0.0000 |
| 542 |
EPISTAXIS |
1 |
0.0000 |
| 543 |
HALLUCINATION |
1 |
0.0000 |
| 544 |
CHRONIC KIDNEY DISEASE |
1 |
0.0000 |
| 545 |
FEELING ABNORMAL |
3 |
0.0000 |
| 546 |
THROMBOSIS |
1 |
0.0000 |
| 547 |
DRY MOUTH |
1 |
0.0000 |
| 548 |
INFLUENZA LIKE ILLNESS |
1 |
0.0000 |
| 549 |
CARDIAC ARREST |
1 |
0.0000 |
| 550 |
CEREBROVASCULAR ACCIDENT |
2 |
0.0000 |
| 551 |
MALAISE |
5 |
0.0000 |
| 552 |
COVID-19 |
2 |
0.0000 |
| 553 |
PAIN |
7 |
0.0000 |
| 554 |
ADVERSE DRUG REACTION |
1 |
0.0000 |
| 555 |
SUICIDAL IDEATION |
1 |
0.0000 |
| 556 |
HYPERSENSITIVITY |
2 |
0.0000 |
| 557 |
CONTUSION |
1 |
0.0000 |
| 558 |
FLUSHING |
1 |
0.0000 |
| 559 |
CHEST DISCOMFORT |
1 |
0.0000 |
| 560 |
OVERDOSE |
2 |
0.0000 |
| 561 |
MUSCULAR WEAKNESS |
1 |
0.0000 |
| 562 |
DEPRESSION |
2 |
0.0000 |
| 563 |
SEIZURE |
1 |
0.0000 |
| 564 |
DISEASE PROGRESSION |
1 |
0.0000 |
| 565 |
EMOTIONAL DISTRESS |
1 |
0.0000 |
| 566 |
DRY SKIN |
1 |
0.0000 |
| 567 |
ARTHRALGIA |
3 |
0.0000 |
| 568 |
PAIN IN EXTREMITY |
2 |
0.0000 |
| 569 |
BLOOD PRESSURE INCREASED |
1 |
0.0000 |
| 570 |
CONFUSIONAL STATE |
1 |
0.0000 |
| 571 |
DRUG DOSE OMISSION |
1 |
0.0000 |
| 572 |
MUSCLE SPASMS |
1 |
0.0000 |
| 573 |
NASOPHARYNGITIS |
1 |
0.0000 |
| 574 |
ALOPECIA |
1 |
0.0000 |
| 575 |
SOMNOLENCE |
1 |
0.0000 |
| 576 |
WRONG TECHNIQUE IN PRODUCT USAGE PROCESS |
1 |
0.0000 |
| 577 |
HYPERTENSION |
1 |
0.0000 |
| 578 |
INSOMNIA |
1 |
0.0000 |